APPLICATION
ANDA076683
TYPE
ANDA
ORIGINAL APPROVAL
2005-04-18
LATEST ACTION
2024-05-09
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued
Products
ANAGRELIDE HYDROCHLORIDEDiscontinued
ANAGRELIDE HYDROCHLORIDE EQ 0.5MG BASE · CAPSULE · ORAL
ANAGRELIDE HYDROCHLORIDEDiscontinued
ANAGRELIDE HYDROCHLORIDE EQ 1MG BASE · CAPSULE · ORAL
Approval history
2024-05-09Labeling · Supplement 11 · standardAP
2019-12-31Labeling · Supplement 8 · standardAP
2015-06-01Labeling · Supplement 7 · standardAP
2015-06-01Labeling · Supplement 6 · standardAP
2012-11-13Labeling · Supplement 5AP
2012-11-13Labeling · Supplement 4AP
2010-08-31Labeling · Supplement 3AP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.